Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00732621
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
5Z5 | 5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO- 3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]- 2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE | A | 2JAV | 0.72 | |
2EQ | 5-(5-chloro-2,4-dihydroxyphenyl)- N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole- 3-carboxamide | A | 2VCJ | 0.72 | |
136 | N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)- 2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE | B | 1GJD | 0.74 | |
CXN | CLOXACILLIN | A,B | 1FCM | 0.78 | |
GNI | (3-{4-[2-(2,4-DICHLORO-PHENOXY)- ETHYLCARBAMOYL]-5-PHENYL-ISOXAZOL- 3-YL}-PHENYL)-ACETIC ACID | A,B | 2J14 | 0.77 | |
6C3 | 6-CHLORO-3-(3-METHYLISOXAZOL-5- YL)-4-PHENYLQUINOLIN-2(1H)-ONE | A | 2I0V | 0.85 | |
PXB | parecoxib | A | 2ZMB | 0.72 | |
AAP | ALPHA-(2,6-DICHLOROPHENYL)-ALPHA- (2-ACETYL-5-METHYLANILINO)ACETAMIDE | A | 1VRU | 0.72 | |
AAP | ALPHA-(2,6-DICHLOROPHENYL)-ALPHA- (2-ACETYL-5-METHYLANILINO)ACETAMIDE | A | 1HPZ | 0.72 | |
J60 | 5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO- 3H-INDOL-3-YLIDENE)METHYL]-N-[2- (DIETHYLAMINO)ETHYL]-2,4-DIMETHYL- 1H-PYRROLE-3-CARBOXAMIDE | A,B | 2JAM | 0.71 | |
AG7 | 4-{2-(4-FLUORO-BENZYL)-6-METHYL- 5-[(5-METHYL-ISOXAZOLE-3-CARBONYL)- AMINO]-4-OXO-HEPTANOYLAMINO}-5- (2-OXO-PYRROLIDIN-3-YL)-PENTANOIC ACID ETHYL ESTER | A | 1CQQ | 0.73 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A | 2HOB | 0.7 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2AMQ | 0.7 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B,C,D | 3D23 | 0.7 | |
3IH | N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL- L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)- 4-OXO-1-{[(3R)-2-OXOPYRROLIDIN- 3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | A,B | 2Q6F | 0.7 | |
A96 | 6-chloro-N-pyrimidin-5-yl-3-{[3- (trifluoromethyl)phenyl]amino}- 1,2-benzisoxazole-7-carboxamide | A,B | 3DTW | 0.71 | |
CXZ | 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]- 1,2-benzisoxazol-3-yl}benzene-1,3- diol | A | 3BMY | 0.72 | |
105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A | 1JWZ | 0.88 | |
105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A,B | 1FSY | 0.88 | |
105 | N-[5-METHYL-3-O-TOLYL-ISOXAZOLE- 4-CARBOXYLIC ACID AMIDE] BORONIC ACID | A | 1NYY | 0.88 | |
19B | 4-methyl-N-(3-morpholin-4-ylphenyl)- 3-(3-piperidin-4-yl-1,2-benzisoxazol- 6-yl)benzamide | A | 3E93 | 0.74 | |
452 | 2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID | A,B | 2QE2 | 0.71 | |
IIA | 1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL- 3-YL]METHYL}-N-(1-ISOPROPYLPIPERIDIN- 4-YL)-1H-INDOLE-2-CARBOXAMIDE | A,B | 2BOH | 0.71 | |
SOY | OXACILLIN-ACYLATED SERINE | A | 2IWD | 0.73 | |
2GG | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)- N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE- 3-CARBOXAMIDE | A | 2UWD | 0.73 |